These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 27609146)

  • 1. Unraveling cellular pathways contributing to drug-induced liver injury by dynamical modeling.
    Kuijper IA; Yang H; Van De Water B; Beltman JB
    Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):5-17. PubMed ID: 27609146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic imaging of adaptive stress response pathway activation for prediction of drug induced liver injury.
    Wink S; Hiemstra SW; Huppelschoten S; Klip JE; van de Water B
    Arch Toxicol; 2018 May; 92(5):1797-1814. PubMed ID: 29502165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
    Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
    Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transduction pathways involved in drug-induced liver injury.
    Han D; Shinohara M; Ybanez MD; Saberi B; Kaplowitz N
    Handb Exp Pharmacol; 2010; (196):267-310. PubMed ID: 20020266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiosyncratic drug-induced liver injury: an update on the 2007 overview.
    Hussaini SH; Farrington EA
    Expert Opin Drug Saf; 2014 Jan; 13(1):67-81. PubMed ID: 24073714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced liver injury: Advances in mechanistic understanding that will inform risk management.
    Mosedale M; Watkins PB
    Clin Pharmacol Ther; 2017 Apr; 101(4):469-480. PubMed ID: 27861792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver injury caused by drugs: an update.
    Stirnimann G; Kessebohm K; Lauterburg B
    Swiss Med Wkly; 2010; 140():w13080. PubMed ID: 20927685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causality assessment for suspected DILI during clinical phases of drug development.
    Regev A; Seeff LB; Merz M; Ormarsdottir S; Aithal GP; Gallivan J; Watkins PB
    Drug Saf; 2014 Nov; 37 Suppl 1(Suppl 1):S47-56. PubMed ID: 25352327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high content screening assay to predict human drug-induced liver injury during drug discovery.
    Persson M; Løye AF; Mow T; Hornberg JJ
    J Pharmacol Toxicol Methods; 2013; 68(3):302-13. PubMed ID: 23933113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced liver injury.
    Holt M; Ju C
    Handb Exp Pharmacol; 2010; (196):3-27. PubMed ID: 20020257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of immune reactions in drug-induced liver injury (DILI).
    Ju C; Reilly T
    Drug Metab Rev; 2012 Feb; 44(1):107-15. PubMed ID: 22235834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals.
    Lammert C; Einarsson S; Saha C; Niklasson A; Bjornsson E; Chalasani N
    Hepatology; 2008 Jun; 47(6):2003-9. PubMed ID: 18454504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced liver injury: what was new in 2013?
    Chalhoub WM; Sliman KD; Arumuganathan M; Lewis JH
    Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):959-80. PubMed ID: 24746272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-Induced Liver Injury and Individual Cell Models.
    Benesic A; Gerbes AL
    Dig Dis; 2015; 33(4):486-91. PubMed ID: 26159263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review.
    Atallah E; Freixo C; Alvarez-Alvarez I; Cubero FJ; Gerbes AL; Kullak-Ublick GA; Aithal GP
    Expert Opin Drug Metab Toxicol; 2021 Nov; 17(11):1327-1343. PubMed ID: 34727797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man.
    Dragovic S; Vermeulen NP; Gerets HH; Hewitt PG; Ingelman-Sundberg M; Park BK; Juhila S; Snoeys J; Weaver RJ
    Arch Toxicol; 2016 Dec; 90(12):2979-3003. PubMed ID: 27659300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: drug-induced liver injury in clinical practice.
    Björnsson E
    Aliment Pharmacol Ther; 2010 Jul; 32(1):3-13. PubMed ID: 20374223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced liver injury: a safety review.
    García-Cortés M; Ortega-Alonso A; Lucena MI; Andrade RJ;
    Expert Opin Drug Saf; 2018 Aug; 17(8):795-804. PubMed ID: 30059261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research Progress on the Animal Models of Drug-Induced Liver Injury: Current Status and Further Perspectives.
    Pan Y; Cao M; You D; Qin G; Liu Z
    Biomed Res Int; 2019; 2019():1283824. PubMed ID: 31119149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury.
    Thakkar S; Chen M; Fang H; Liu Z; Roberts R; Tong W
    Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):31-38. PubMed ID: 28931315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.